| Date | Title | | | 12/17/07 | Raptor Pharmaceuticals Acquires Orphan Clinical Program|
Novato, California, December 17, 2007 – Raptor Pharmaceuticals Corp. (“Raptor” or the “Company”) (OTC Bulletin Board: RPTP), today announced that its clinical development division, Bennu Pharmaceuticals Inc. (“Bennu”), has acquired a clinical product candidate, EC Cysteamine. Bennu received the exclusive worldwide license to EC Cysteamine, developed by clinical scientists at the University of California, San Diego, School of Medicine, by way of its acquisition by merger of Encode Phar... |
|  | | 10/22/07 | Raptor Pharmaceuticals Acquires Initial Clinical Program - Establishes Subsidiary to Develop Clinical Phase Drugs|
Novato, California, October 22, 2007 – Raptor Pharmaceuticals Corp. (“Raptor”) (OTC Bulletin Board: RPTP.OB), today announced the acquisition of its first clinical-stage product and the formation of a wholly-owned subsidiary, Bennu Pharmaceuticals Inc. The subsidiary will be responsible for clinical development of internally discovered therapeutic candidates based on Raptor Pharmaceutical's novel drug delivery platforms and in-licensed clinical-stage products. Bennu will focus initi... |
| | | 09/13/07 | Raptor Pharmaceuticals Provides Update of Product Programs |
Poster at Upcoming International Liver Cancer Conference
Status of Ongoing Programs
Regulatory Consulting Firm Retained
Novato, California, September 13, 2007 – Raptor Pharmaceuticals Corp. (“Raptor” or the "Company") (OTC Bulletin Board: RPTP.OB) announced today that Dr. Todd Zankel, the Company's Chief Scientific Officer, will present a poster detailing promising preclinical results from two preclinical studies of its HepTide™ liver targeting program at the International Liv... |
| | | 05/02/07 | Raptor Pharmaceuticals Corp. to Present at BIO International 2007 Business Forum| Novato, California, May 2 , 2007 - Raptor Pharmaceuticals Corp. (the "Company") (OTC Bulletin Board: RPTP.OB) announced today that its Chief Executive Officer, Dr. Christopher M. Starr, has been awarded a speaking platform at the BIO Business Forum at BIO International 2007 in Boston. Dr. Starr's presentation will take place on Tuesday, May 8, 2007, at 10:30 AM in Room E, Boston Convention and Exhibition Center at 425 Summer Street.
Dr. Starr will update attendees on Raptor's pre-clinical pr... |
| | | 04/16/07 | Raptor Announces Fiscal Results, Updates Programs and Appoints Investor Relations Firm| Contact:
John Quirk, Sara Ephraim
The Ruth Group
(646) 536-7029 / 7002
Raptor Pharmaceuticals Corp. Announces Fiscal 2007 Second Quarter Results,
Updates Programs and Appoints Investor Relations Firm
Novato, California, April 16, 2007 - Raptor Pharmaceuticals Corp. (the "Company") (OTC Bulletin Board: RPTP.OB), today announced its quarterly financial results. The Company posted a net loss for the three and six months ended February 28, 2007, of $721,000 and $1,524,000, respec... |
| |
|
